These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16080519)

  • 1. Exogenous expression of hRFI induces multidrug resistance through escape from apoptosis in colorectal cancer cells.
    Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
    Anticancer Res; 2005; 25(4):2737-41. PubMed ID: 16080519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
    Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
    Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of hRFI (human ring finger homologous to inhibitor of apoptosis protein type) inhibits death receptor-mediated apoptosis in colorectal cancer cells.
    Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
    Mol Cancer Ther; 2005 May; 4(5):743-50. PubMed ID: 15897238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hRFI overexpressed in HCT116 cells modulates Bcl-2 family proteins when treated with 5-fluorouracil.
    Sasaki S; Watanabe T; Kobunai T; Konishi T; Nagase H; Sugimoto Y; Oka T; Nagawa H
    Oncol Rep; 2006 May; 15(5):1293-8. PubMed ID: 16596200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancer.
    Allen WL; Stevenson L; Coyle VM; Jithesh PV; Proutski I; Carson G; Gordon MA; Lenz HJ; Van Schaeybroeck S; Longley DB; Johnston PG
    Mol Cancer Ther; 2012 Jan; 11(1):119-31. PubMed ID: 22027693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-mediated pro-apoptotic interaction of panaxadiol and irinotecan in human colorectal cancer cells.
    Du GJ; Wang CZ; Zhang ZY; Wen XD; Somogyi J; Calway T; He TC; Du W; Yuan CS
    J Pharm Pharmacol; 2012 May; 64(5):727-34. PubMed ID: 22471369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of expression of hRFI on adenoma formation and tumor progression in colorectal adenoma-carcinoma sequence.
    Sasaki S; Watanabe T; Konishi T; Kitayama J; Nagawa H
    J Exp Clin Cancer Res; 2004 Sep; 23(3):507-12. PubMed ID: 15595643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms.
    Coudray AM; Louvet C; Kornprobst M; Raymond E; André T; Tournigand C; Faivre S; De Gramont A; Larsen AK; Gespach C
    Int J Oncol; 2005 Aug; 27(2):553-61. PubMed ID: 16010439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells.
    Shang J; Yang F; Wang Y; Wang Y; Xue G; Mei Q; Wang F; Sun S
    J Cell Biochem; 2014 Apr; 115(4):772-84. PubMed ID: 24249161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
    Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
    Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of a novel gene, hRFI, preferentially expressed in esophageal cancer.
    Sasaki S; Nakamura T; Arakawa H; Mori M; Watanabe T; Nagawa H; Croce CM
    Oncogene; 2002 Jul; 21(32):5024-30. PubMed ID: 12118383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoA regulates resistance to irinotecan by regulating membrane transporter and apoptosis signaling in colorectal cancer.
    Ruihua H; Mengyi Z; Chong Z; Meng Q; Xin M; Qiulin T; Feng B; Ming L
    Oncotarget; 2016 Dec; 7(52):87136-87146. PubMed ID: 27888624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
    Zhang Y; Talmon G; Wang J
    Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells.
    Costantino E; Maddalena F; Calise S; Piscazzi A; Tirino V; Fersini A; Ambrosi A; Neri V; Esposito F; Landriscina M
    Cancer Lett; 2009 Jun; 279(1):39-46. PubMed ID: 19217207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irinotecan/5-fluorouracil combination induces alterations in mitochondrial membrane potential and caspases on colon cancer cell lines.
    Grivicich I; Regner A; da Rocha AB; Grass LB; Alves PA; Kayser GB; Schwartsmann G; Henriques JA
    Oncol Res; 2005; 15(7-8):385-92. PubMed ID: 16491956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan.
    Boyer J; McLean EG; Aroori S; Wilson P; McCulla A; Carey PD; Longley DB; Johnston PG
    Clin Cancer Res; 2004 Mar; 10(6):2158-67. PubMed ID: 15041737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.
    McDermott U; Longley DB; Galligan L; Allen W; Wilson T; Johnston PG
    Cancer Res; 2005 Oct; 65(19):8951-60. PubMed ID: 16204068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein 27 is associated with irinotecan resistance in human colorectal cancer cells.
    Choi DH; Ha JS; Lee WH; Song JK; Kim GY; Park JH; Cha HJ; Lee BJ; Park JW
    FEBS Lett; 2007 Apr; 581(8):1649-56. PubMed ID: 17395183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
    Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
    Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Recombinant Circularly Permuted Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) (Recombinant Mutant Human TRAIL) in Combination with 5-Fluorouracil in Human Colorectal Cancer Cell Lines HCT116 and SW480.
    Sun T; Zhu T; Liang X; Yang S; Zhao R
    Med Sci Monit; 2018 Apr; 24():2550-2561. PubMed ID: 29695684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.